Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced that the first patient has been dosed in ZENITH (ZilebEsiraN CardIovascular OuTcome Study in ...
The event, supported by the Cal Ripken Sr. Foundation, aimed to teach students core concepts from science, technology, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback